Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply
14 Jun 2019 //
FIERCE PHARMA
Over 100 lots of losartan tablets recalled after NMBA detected
30 Apr 2019 //
IN-PHARMATECHNOLOGIST
EMA Urges Pioglitazone Manufacturers to Check for Nitrosamine Impurities
26 Apr 2019 //
RAPS
To Prevent Losartan Shortages, FDA Allows Higher Impurity Levels
22 Mar 2019 //
RAPS
FDA updates on recalls of valsartan, losartan and irbesartan
20 Mar 2019 //
FDA
Legacy Pharmaceutical Packaging Issues Recall of Losartan Potassium Tablets
19 Mar 2019 //
FDA
Camber Pharmaceuticals Voluntarily Recalls Losartan Potassium Tablets
01 Mar 2019 //
FDA
Update on the EDQM review of CEP applications for sartan substances (4 Feb 2019)
04 Feb 2019 //
EDQM